Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Today, Zacks Equity Research discusses Eli Lilly LLY, Johnson & Johnson JNJ, Sanofi SNY and Bayer BAYRY. Industry: Large-Cap ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...

A new tumor necrosis factor alpha (TNF-α) blocker with a unique once-monthly dosing schedule has been approved, but despite its advantages, few believe it will shake up the market. Simponi (golimumab) ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The drug and biotech sector has recovered somewhat in 2026 after remaining muted for most of 2025. Drug pricing agreements of ...

Global specialty, generic and consumer healthcare medicines company STADA and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and ...

Launch preparations are underway to bring the second approved golimumab biosimilar to patients across Europe in the coming weeks and months Bio-Thera is responsible for development, manufacture and ...

Ivermectin is a medication that treats some parasitic diseases. There are two types: one that doctors prescribe for certain health conditions in people and another that veterinarians prescribe, which ...

Understanding your clonazepam dosage is an important step in managing your health. This guide breaks down the standard strengths and instructions found in the drug’s prescribing information, helping ...

Ozempic is prescribed for adults with type 2 diabetes. It’s given as an injection under the skin once per week. The recommended starting dose of Ozempic is 0.25 milligrams (mg) injected once per week.

In the long and often dispiriting quest to cure cancer, the 1998 approval of the drug Herceptin was a tremendously hopeful moment. This drug for breast cancer was the first to use a tumor-specific ...